Cancer Letters
Skin cancer prevention – Recent advances and unmet challenges
Publication date: Available online 19 September 2023Source: Cancer LettersAuthor(s): Mahsa Mortaja, Shadmehr Demehri
Cancer Letters
Targeting YB-1 via entinostat enhances cisplatin sensitivity of pleural mesothelioma <em>in vitro</em> and <em>in vivo</em>
Publication date: Available online 18 September 2023Source: Cancer LettersAuthor(s): Karin Schelch, Dominik Emminger, Benjamin Zitta, Thomas G. Johnson, Verena Kopatz, Sebastian Eder, Alexander Ries, Alessia Stefanelli, Petra Heffeter, Mir A. Hoda, Kon…
Cancer Letters
Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment
Publication date: Available online 18 September 2023Source: Cancer LettersAuthor(s): Mengdan Xu, Shenglong Li
Cancer Letters
EMP3 as a key downstream target of miR-663a regulation interferes with MAPK/ERK signaling pathway to inhibit gallbladder cancer progression
Publication date: Available online 18 September 2023Source: Cancer LettersAuthor(s): Qiang Ma, Yijian Zhang, Haibin Liang, Fei Zhang, Fatao Liu, Shili Chen, Yunping Hu, Lin Jiang, Yajuan Hao, Maolan Li, Yingbin Liu
Cancer Letters
Multi-omic analysis reveals metabolic pathways that characterize right-sided colon cancer liver metastasis
Publication date: Available online 14 September 2023Source: Cancer LettersAuthor(s): Montana T. Morris, Abhishek Jain, Boshi Sun, Vadim Kurbatov, Engjel Muca, Zhaoshi Zeng, Ying Jin, Jatin Roper, Jun Lu, Philip B. Paty, Caroline H. Johnson, Sajid A. Khan
Cancer Letters
Biological characteristics of pancreatic ductal adenocarcinoma: Initiation to malignancy, intracellular to extracellular
Publication date: Available online 14 September 2023Source: Cancer LettersAuthor(s): Ou Li, Li Li, Yunru Sheng, Kun Ke, Jianzhang Wu, Yiping Mou, Mingyang Liu, Weiwei Jin
Cancer Letters
Exosomes as emerging nanoplatform in cancer therapy
Publication date: Available online 15 September 2023Source: Cancer LettersAuthor(s): Farrukh Aqil, Ramesh Gupta
Cancer Letters
Editorial Board
Publication date: 1 October 2023Source: Cancer Letters, Volume 573Author(s):
Cancer Letters
Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer
Publication date: Available online 14 September 2023Source: Cancer LettersAuthor(s): Prabhakar Pitta Venkata, Sridharan Jayamohan, Yi He, Salvador Alejo, Jessica D. Johnson, Bridgitte E. Palacios, Uday P. Pratap, Yihong Chen, Zexuan Liu, Yi Zou, Zhao L…
Cancer Letters
PARPing up the right tree; an overview of PARP inhibitors for metastatic castration-resistant prostate cancer
Publication date: Available online 7 September 2023Source: Cancer LettersAuthor(s): Peter H.J. Slootbeek, Joanneke K. Overbeek, Marjolijn J.L. Ligtenberg, Nielka P. van Erp, Niven Mehra